FDA approval of the first freeze-dried plasma product in the United States, intended for transfusion in adult patients when other plasma products are unavailable (e.g., combat zones, rural areas, disaster settings).
The FDA approved a freeze-dried plasma product that is stable at room temperature and can be rapidly reconstituted, unlike traditional plasma which requires freezing and thawing.
This is a brief news item; no clinical trial data, efficacy outcomes, safety data, or sample sizes are reported in the available text.
Clinicians in austere or resource-limited settings (military, rural, disaster response) may now have access to a room-temperature-stable plasma product that does not require a cold chain or thawing before use.
Explore related topics
